San Diego Venture Funding Plunges in Fourth-Quarter; Our Top 10 Deals

Bruce V. Bigelow1/18/13Follow @bvbigelow

Share and Comment

Leave a Comment Order a Reprint E-mail this Story

• Share on Twitter
• Share on Facebook


• Share on Linkedin
• Share on Google
• Submit to Hacker News

(Page 2 of 2)

the life sciences and tech, cleantech, and Internet deals.

Based on MoneyTree data, San Diego’s top 10 venture deals during the fourth quarter were:

Ambit Biosciences, $21.7 million.

Lithera, $20.6 million.

Tandem Diabetes Care, $20 million.

Cebix, $18 million.

Auspex Pharmaceuticals, $17.49 million.

PatientSafe Solutions, $13.28 million.

Epic Sciences, $13 million.

Avelas Biosciences, $7.65 million.

MabVax Therapeutics, $5.25 million.

SmartDrive Systems, $5 million.
_____

Based on MoneyTree data, the top 10 venture deals of 2012 in San Diego were:

Sapphire Energy, $141.9 million.

Aragon Pharmaceuticals, $87.8 million.

Tandem Diabetes Care, $55.2 million.

Celladon, $52.2 million.

SmartDrive Systems, $52 million.

Sangart, $50.74 million.

Astute Medical, $40.45 million.

Genomatica, $34.5 million.

Cebix, $30.9 million

Global Analytics, $25 million.

Bruce V. Bigelow is the editor of Xconomy San Diego. You can e-mail him at bbigelow@xconomy.com or call (619) 669-8788 Follow @bvbigelow